{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:52:07Z","timestamp":1778291527431,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":3632,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jpain.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T21:31:01Z","timestamp":1371245461000},"page":"1097-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["An Opposite-Direction Modulation of the COMT Val158Met Polymorphism on the Clinical Response to Intrathecal Morphine and Triptans"],"prefix":"10.1016","volume":"14","author":[{"given":"Sarah","family":"Cargnin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Mittino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Cantello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Sances","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Canonico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando A.","family":"Genazzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Raffaeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Terrazzino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2013.04.006_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/pgs.09.13","article-title":"Variation in the COMT gene: Implications for pain perception and pain treatment","volume":"10","author":"Andersen","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jpain.2013.04.006_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejpain.2004.06.005","article-title":"COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population","volume":"9","author":"Armero","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10194-007-0388-5","article-title":"Association study between clinical response to rizatriptan and some candidate genes","volume":"8","author":"Asuni","year":"2007","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroimage.2005.05.030","article-title":"COMT Val108\/158Met genotype affects the mu-opioid receptor system in the human brain: Evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression","volume":"28","author":"Berthele","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.jpain.2013.04.006_bib5","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/sj.npp.1300542","article-title":"The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes","volume":"29","author":"Bilder","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpain.2013.04.006_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-2982.2008.01687.x","article-title":"Pathways to the best fit of triptans for migraine patients","volume":"28","author":"Buzzi","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2013.04.006_bib7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/bmj.38281.595718.7C","article-title":"Parenteral metoclopramide for acute migraine: Meta-analysis of randomised controlled trials","volume":"329","author":"Colman","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jpain.2013.04.006_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1526-4637.2004.04011.x","article-title":"Intrathecal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain","volume":"5","author":"Deer","year":"2004","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2013.04.006_bib9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-1403.2007.00128.x","article-title":"Polyanalgesic Consensus Conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel","volume":"10","author":"Deer","year":"2007","journal-title":"Neuromodulation"},{"key":"10.1016\/j.jpain.2013.04.006_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddi013","article-title":"Genetic basis for individual variations in pain perception and the development of a chronic pain condition","volume":"14","author":"Diatchenko","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpain.2013.04.006_bib11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1742-1241.2006.00981.x","article-title":"Review of clinical trials using early acute intervention with oral triptans for migraine management","volume":"60","author":"Dowson","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jpain.2013.04.006_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clpt.2003.10.006","article-title":"A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity","volume":"75","author":"Duguay","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpain.2013.04.006_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pharmthera.2012.08.011","article-title":"Basic mechanisms of migraine and its acute treatment","volume":"136","author":"Edvinsson","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jpain.2013.04.006_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.36076\/ppj.2011\/14\/343","article-title":"Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain","volume":"14","author":"Grider","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpain.2013.04.006_bib15","doi-asserted-by":"crossref","first-page":"e48135","DOI":"10.1371\/journal.pone.0048135","article-title":"Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome","volume":"710","author":"Hall","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2013.04.006_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10072-011-0716-z","article-title":"Negative predictors of clinical response to triptans in patients with migraine","volume":"33","author":"Ishii","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jpain.2013.04.006_bib17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0028-3908(03)00286-7","article-title":"Human catechol-O-methyltransferase down-regulation by estradiol","volume":"45","author":"Jiang","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpain.2013.04.006_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/dmd.106.012294","article-title":"Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: Comparison of unbound concentration ratios to in\u00a0vivo p-glycoprotein efflux ratios","volume":"35","author":"Kalvass","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpain.2013.04.006_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-381326-8.00010-7","article-title":"Catechol-O-methyltransferase and pain","volume":"95","author":"Kambur","year":"2010","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.jpain.2013.04.006_bib20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.pain.2011.01.040","article-title":"Influence from genetic variability on opioid use for cancer pain: A European Genetic Association study of 2294 cancer pain patients","volume":"152","author":"Klepstad","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib21","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1399-6576.2004.00517.x","article-title":"The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease","volume":"48","author":"Klepstad","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jpain.2013.04.006_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2011.11.008","article-title":"Impact of the COMT Val(108\/158)Met polymorphism on the mu-opioid receptor system in the human brain: Mu-opioid receptor, met-enkephalin and beta-endorphin expression","volume":"506","author":"Kowarik","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2013.04.006_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0025-7125(05)70134-6","article-title":"Interventional pain management: Appropriate when less invasive therapies fail to provide adequate analgesia","volume":"83","author":"Krames","year":"1999","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jpain.2013.04.006_bib24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00003088-200443140-00003","article-title":"Genetic predictors of the clinical response to opioid analgesics: Clinical utility and future perspectives","volume":"43","author":"L\u00f6tsch","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpain.2013.04.006_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/FPC.0b013e32832b89da","article-title":"Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers","volume":"19","author":"L\u00f6tsch","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jpain.2013.04.006_bib26","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/bi00013a008","article-title":"Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme","volume":"34","author":"Lotta","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.jpain.2013.04.006_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11940-011-0150-9","article-title":"Use of dopamine antagonists in treatment of migraine","volume":"14","author":"Marmura","year":"2012","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.jpain.2013.04.006_bib28","first-page":"1393","article-title":"Expression changes in arrestin \u03b21 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients","volume":"27","author":"Matsuoka","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jpain.2013.04.006_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-8069-6-32","article-title":"The val158met polymorphism of\u00a0human catechol-O-methyltransferase (COMT) affects anterior cingulate cortex activation in response to painful laser stimulation","volume":"6","author":"Mobascher","year":"2010","journal-title":"Mol Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-1-60327-323-7_28","article-title":"Assessing potential functionality of catechol-O-methyltransferase (COMT) polymorphisms associated with pain sensitivity and temporomandibular joint disorders","volume":"617","author":"Nackley","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jpain.2013.04.006_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pain.2006.09.022","article-title":"Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors","volume":"128","author":"Nackley","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3988\/jcn.2007.3.1.24","article-title":"Genetic contribution of catechol-O-methyltransferase polymorphism in patients with migraine without aura","volume":"3","author":"Park","year":"2007","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.jpain.2013.04.006_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1468-2982.1996.1605317.x","article-title":"Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain","volume":"16","author":"Pascual","year":"1996","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2013.04.006_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1526-4610.1998.3801018.x","article-title":"Beyond monotherapy: Rational polytherapy in migraine","volume":"38","author":"Peroutka","year":"1998","journal-title":"Headache"},{"key":"10.1016\/j.jpain.2013.04.006_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000414627","article-title":"Cholinergic and catecholaminergic modulation of nociceptive reactions. Interactions with opiates","volume":"9","author":"Pert","year":"1987","journal-title":"Pain Headache"},{"key":"10.1016\/j.jpain.2013.04.006_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2006.08.001","article-title":"Noradrenergic pain modulation","volume":"80","author":"Pertovaara","year":"2006","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jpain.2013.04.006_bib37","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1007\/s10194-004-0122-5","article-title":"Different characteristics of triptans","volume":"5","author":"Pini","year":"2004","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1525-1403.2006.00071.x","article-title":"Intraspinal therapy for the treatment of chronic pain: A review of the literature between 1990 and 2005 and suggested protocol for its rational and safe use","volume":"9","author":"Raffaeli","year":"2006","journal-title":"Neuromodulation"},{"key":"10.1016\/j.jpain.2013.04.006_bib39","series-title":"Topics in Neuromodulation Treatment","first-page":"111","article-title":"Intrathecal drug administration for the treatment of cancer and non-cancer chronic pain","author":"Raffaeli","year":"2012"},{"key":"10.1016\/j.jpain.2013.04.006_bib40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1017\/S026502150600038X","article-title":"Opioid-related side-effects after intrathecal morphine: A prospective, randomized, double-blind dose-response study","volume":"23","author":"Raffaeli","year":"2006","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jpain.2013.04.006_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pain.2005.03.032","article-title":"The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients","volume":"116","author":"Rakv\u00e5g","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1744-8069-4-64","article-title":"Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain","volume":"4","author":"Rakv\u00e5g","year":"2008","journal-title":"Mol Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pain.2006.10.023","article-title":"Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene","volume":"130","author":"Reyes-Gibby","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2217\/14622416.9.7.905","article-title":"Pharmacogenetics of analgesics: Toward the individualization of prescription","volume":"9","author":"Rollason","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jpain.2013.04.006_bib45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/cncr.23292","article-title":"Genetic variation and response to morphine in cancer patients: Catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects","volume":"112","author":"Ross","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jpain.2013.04.006_bib46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1526-4610.2003.03130.x","article-title":"Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs","volume":"4","author":"Schulman","year":"2003","journal-title":"Headache"},{"key":"10.1016\/j.jpain.2013.04.006_bib47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/ALN.0b013e318182af21","article-title":"A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia","volume":"109","author":"Sia","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpain.2013.04.006_bib48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijoa.2010.03.001","article-title":"The influence of ATP-binding cassette sub-family B member -1 (ABCB1) genetic polymorphisms on acute and chronic pain after intrathecal morphine for caesarean section: A prospective cohort study","volume":"19","author":"Sia","year":"2010","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.jpain.2013.04.006_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.WNL.0000042477.63516.B2","article-title":"Acute migraine treatment with droperidol: A\u00a0randomized, double-blind, placebo-controlled trial","volume":"60","author":"Silberstein","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2013.04.006_bib50","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.55.6.754","article-title":"Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Silberstein","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2013.04.006_bib51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/FPC.0b013e3283560c46","article-title":"Catechol-O-methyltransferase gene polymorphism and chronic human pain: A systematic review and meta-analysis","volume":"22","author":"Tammim\u00e4ki","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jpain.2013.04.006_bib52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/FPC.0b013e328337f9ab","article-title":"Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: A randomized, double-blind, placebo-controlled, crossover pilot study","volume":"20","author":"Tchivileva","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jpain.2013.04.006_bib53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2010.04.049","article-title":"The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients","volume":"641","author":"Terrazzino","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpain.2013.04.006_bib54","first-page":"65","article-title":"Guidelines for\u00a0controlled trials of drugs in migraine: Second edition","volume":"20","author":"Tfelt-Hansen","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2013.04.006_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10194-009-0170-y","article-title":"Does sumatriptan cross the blood\u2013brain barrier in animals and man?","volume":"11","author":"Tfelt-Hansen","year":"2010","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2013.04.006_bib56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/mol.56.1.31","article-title":"Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription","volume":"56","author":"Xie","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jpain.2013.04.006_bib57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0091-3057(85)90537-4","article-title":"Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing","volume":"22","author":"Yaksh","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jpain.2013.04.006_bib58","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.1078546","article-title":"COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor","volume":"299","author":"Zubieta","year":"2003","journal-title":"Science"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590013009681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590013009681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:56:54Z","timestamp":1761508614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590013009681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1526590013009681"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2013.04.006","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Opposite-Direction Modulation of the COMT Val158Met Polymorphism on the Clinical Response to Intrathecal Morphine and Triptans","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}